| Keywords: |
immunohistochemistry; treatment outcome; overall survival; clinical feature; cisplatin; cancer radiotherapy; molecular genetics; antineoplastic agent; cytology; electron microscopy; microscopy, electron; diagnostic procedure; disease association; tumor localization; carboplatin; computer assisted tomography; diagnosis, differential; tumor volume; etoposide; lung lobectomy; lung non small cell cancer; carcinoma, non-small-cell lung; lung neoplasms; differential diagnosis; gene frequency; cell differentiation; pathology; cell transformation, neoplastic; neuroendocrine tumor; lung tumor; lung small cell cancer; disease severity; hyperplasia; carcinoid; platinum derivative; large cell carcinoma; cancer classification; molecular biology; lung biopsy; multiple cancer; neuroendocrine tumors; small cell lung carcinoma; diffuse idiopathic pulmonary neuroendocrine cell hyperplasia; large cell neuroendocrine carcinoma; neuroendocrine cell hyperplasia; neuroendocrine cells
|
